Search

Your search keyword '"Stanford, Janet"' showing total 127 results

Search Constraints

Start Over You searched for: Author "Stanford, Janet" Remove constraint Author: "Stanford, Janet" Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
127 results on '"Stanford, Janet"'

Search Results

1. Supplementary Table 1 from Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study

3. Supplementary Figure 1 from Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study

4. Germline genetic variants associated with somatic TMPRSS2:ERG fusion status in prostate cancer: a genome-wide association study

5. Abstract 3508: Association between clonal hematopoiesis and risk of prostate cancer in a large sample of African ancestry men

6. Abstract 1182: Association of prostate cancer candidate genes with overall and aggressive prostate cancer in men of African ancestry

7. Data from A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer

8. Supplementary Figure 1 from A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer

9. Supplementary Methods, Figures S1 - S3 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

10. Supplementary Tables S1 - S10 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

11. Supp. Table S22 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

12. Data from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

13. Supp. Tables S1, S3-S15, S20, and S23 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

14. Supplementary Table 1 from A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer

15. Supplementary Acknowledgments from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

16. Supp. Tables S16-S19 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

17. Data from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

18. Supplementary Tables 2 - 5, Figures 2 - 3 from A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer

19. Supplementary Grant Support from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

20. Supp. Figures and Legends from Genetic Mechanisms of Immune Evasion in Colorectal Cancer

21. Supplementary notes from Genome-Wide Association Study of Prostate Cancer–Specific Survival

22. Data from Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

23. Supplementary Data from Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality

24. Data from Genome-Wide Association Study of Prostate Cancer–Specific Survival

25. Supplementary Table 1 from Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality

27. Data from Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality

30. Supplementary Figure 1 from Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

31. Supplementary Tables 1-8 from Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

33. Data from Validation of Genome-Wide Prostate Cancer Associations in Men of African Descent

34. Supplementary Table 2 from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

37. Supplementary Table 3 from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

39. Supplementary Figure 1 from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

40. Data from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

41. Supplementary Notes from Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

42. Supplementary Figure Legend from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

43. Supplementary Figure 3 from Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

44. Supplemental Table 1 from Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer

45. Supplementary Table 1 from Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

46. Supplementary Figure 2 from Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

47. Supplementary Materials from Validation of Genome-Wide Prostate Cancer Associations in Men of African Descent

50. Abstract 3517: A germline variant at 8q24 contributes to familial clustering of prostate cancer in men of African ancestry

Catalog

Books, media, physical & digital resources